(Hypertension. 1996;28:791-796.)
© 1996 American Heart Association, Inc.
Articles |
Left Ventricular Hypertrophy and QT Dispersion in Hypertension
The Peart-Rose Clinic (J.M., N.R.P., P.S.S., S.A.McG.T.) and Department of Cardiology (J.M., M.S., K.McG., R.A.F.), St Mary's Hospital, London, UK.
Correspondence to Dr Jamil Mayet, Department of Clinical Pharmacology, 10th Floor QEQM Wing, St Mary's Hospital, Praed St, Paddington, London W2 1NY, UK.
The interlead variation in QT length on a standard electrocardiograph reflects regional repolarization differences in the heart. To investigate the association between this interlead variation (QT dispersion) and left ventricular hypertrophy, we subjected 100 untreated subjects to 12-lead electrocardiography and echocardiography. Additionally, 24 previously untreated subjects underwent a 6-month treatment study with ramipril and felodipine. In the cross-sectional part of the study, QT dispersion corrected for heart rate (QTc dispersion) was significantly correlated with left ventricular mass index (r=.30, P<.01), systolic pressure (r=.30, P<.01), the ratio of peak flow velocity of the early filling wave to peak flow velocity of the atrial wave (E/A ratio) (r=-.22, P=.02), isovolumic relaxation time (r=.31, P<.01), and age (r=.21, P<.04). In the treatment part of the study, lead-adjusted QTc dispersion decreased from 24 to 19 milliseconds after treatment, and after a subsequent 2 weeks of drug washout remained at 19 milliseconds (P<.01). The changes in left ventricular mass index at these stages were 144, 121, and 124 g/m2 (P<.01). Systolic pressure decreased from 175 to 144 mm Hg and increased again to 164 mm Hg after drug washout (P<.01).The E/A ratio (0.97, 1.02, and 1.02; P=.69) and isovolumic relaxation time (111, 112, and 112; P=.97) remained unchanged through the three assessment points. In conclusion, QT dispersion is increased in association with an increased left ventricular mass index in hypertensive individuals. Antihypertensive therapy with ramipril and felodipine reduced both parameters. If an increased QT dispersion is a predictor of sudden death in this group of individuals, then the importance of its reduction is evident.
Key Words: hypertrophy • QT dispersion • electrocardiography • antihypertensive agents
This article has been cited by other articles:
 |
|
 |
|
  S. Dimopoulos, F. Nicosia, P. Donati, P. Prometti, M. De Vecchi, R. Zulli, and V. Grassi QT Dispersion and Left Ventricular Hypertrophy in Elderly Hypertensive and Normotensive Patients Angiology, October 1, 2008; 59(5): 605 - 612. [Abstract] [PDF]
|
|
|
|
|
|
A. V. Mattioli, S. Bonatti, and G. Mattioli Left Atrial Anatomy and Function After Conversion From Atrial Fibrillation in Hypertrophic Hearts Angiology, January 1, 2007; 57(6): 717 - 723. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Salles, S. Leocadio, K. Bloch, A. R. Nogueira, and E. Muxfeldt Combined QT Interval and Voltage Criteria Improve Left Ventricular Hypertrophy Detection in Resistant Hypertension Hypertension, November 1, 2005; 46(5): 1207 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wasson, H. K. Reddy, and M. L. Dohrmann Current Perspectives of Electrical Remodeling and Its Therapeutic Implications Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 129 - 144. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Mayet and A. Hughes Cardiac and vascular pathophysiology in hypertension Heart, September 1, 2003; 89(9): 1104 - 1109. [Full Text] [PDF]
|
|
|
|
|
|
K Sakata, M Shimizu, H Ino, M Yamaguchi, H Terai, K Hayashi, M Kiyama, T Hayashi, M Inoue, and H Mabuchi QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy Heart, August 1, 2003; 89(8): 882 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Reddy, S. Wasson, S. K.G. Koshy, and R. Komatireddy Structural correlates of electrical remodeling in ventricular hypertrophy Cardiovasc Res, June 1, 2003; 58(3): 495 - 497. [Full Text] [PDF]
|
|
|
|
|
|
M. Peschar, K. Vernooy, W. Y.R Vanagt, R. S Reneman, M. A Vos, and F. W Prinzen Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles Cardiovasc Res, June 1, 2003; 58(3): 510 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Poulsen Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes Journal of Renin-Angiotensin-Aldosterone System, December 1, 2002; 3(4): 222 - 242. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Covic, M. Diaconita, P. Gusbeth-Tatomir, M. Covic, A. Botezan, G. Ungureanu, and D. J. Goldsmith Haemodialysis increases QTc interval but not QTc dispersion in ESRD patients without manifest cardiac disease Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2170 - 2177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Yildirir, M. K Batur, and A Oto Hypertension and arrhythmia: blood pressure control and beyond Europace, January 1, 2002; 4(2): 175 - 182. [Abstract] [PDF]
|
|
|
|
 |
|
 P. L. Poulsen, E. Ebbehøj, H. Arildsen, S. T. Knudsen, K. W. Hansen, H. Mølgaard, and C. E. Mogensen Increased QTc Dispersion Is Related to Blunted Circadian Blood Pressure Variation in Normoalbuminuric Type 1 Diabetic Patients Diabetes, April 1, 2001; 50(4): 837 - 842. [Abstract] [Full Text]
|
|
|
|
|
|
P. O. Lim, C. A. J. Farquharson, P. Shiels, R. T. Jung, A. D. Struthers, and T. M. MacDonald Adverse Cardiac Effects of Salt With Fludrocortisone in Hypertension Hypertension, March 1, 2001; 37(3): 856 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Malik and V. N. Batchvarov Measurement, interpretation and clinical potential of QT dispersion J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1749 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sahu, P.O. Lim, B.S. Rana, and A.D. Struthers QT dispersion in medicine: electrophysiological Holy Grail or fool's gold? QJM, July 1, 2000; 93(7): 425 - 431. [Full Text] [PDF]
|
|
|
|
|
|
E. Yetkin, M. Ileri, I. Tandogan, M. Boran, A. Yanik, I. Hisar, M. Kutlu, S. Cehreli, S. Korkmaz, S. Goksel, et al. Increased QT Interval Dispersion After Hemodialysis: Role of Peridialytic Electrolyte Gradients Angiology, June 1, 2000; 51(6): 499 - 504. [Abstract] [PDF]
|
|
|
|
 |
|
 G.P. McCann, D.F. Muir, and W.S. Hillis Athletic left ventricular hypertrophy: long-term studies are required Eur. Heart J., March 1, 2000; 21(5): 351 - 353. [PDF]
|
|
|
|
|
|
D Darbar, C J Cherry, and D M Kerins QT dispersion is reduced after valve replacement in patients with aortic stenosis Heart, July 1, 1999; 82(1): 15 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C E Bonnar, A P Davie, L Caruana, L Fenn, S A Ogston, J J V McMurray, and A D Struthers QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion Heart, March 1, 1999; 81(3): 297 - 302. [Abstract] [Full Text]
|
|
|
|
|
|
P. O. Lim, M. Nys, A. A. O. Naas, A. D. Struthers, M. Osbakken, and T. M. MacDonald Irbesartan Reduces QT Dispersion in Hypertensive Individuals Hypertension, February 1, 1999; 33(2): 713 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. W. MORRIS, E. GALIATSOU, G. A. STEWART, R. S. C. RODGER, and A. G. JARDINE QT Dispersion Before and After Hemodialysis J. Am. Soc. Nephrol., January 1, 1999; 10(1): 160 - 163. [Abstract] [Full Text]
|
|